𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Risk of prostate, breast and colorectal cancer after skin cancer diagnosis

✍ Scribed by Fabio Levi; Lalao Randimbison; Van-Cong Te; Manuela Maspoli Conconi; Carlo La Vecchia


Publisher
John Wiley and Sons
Year
2008
Tongue
French
Weight
64 KB
Volume
123
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Ultraviolet radiation is the major cause of skin cancer, but promotes vitamin D synthesis, and vitamin D has been inversely related to the risk of several common cancers including prostate, breast and colorectum. We therefore computed the incidence of prostate, breast and colorectal cancer following skin cancer using the datasets of the Swiss cancer Registries of Vaud and NeuchΓ’tel. Between 1974 and 2005, 6,985 histologically confirmed squamous cell skin cancers, 21,046 basal cell carcinomas and 3,346 cutaneous malignant melanomas were registered, and followed up to the end of 2005 for the occurrence of second primary cancer of the prostate, breast and colorectum. Overall, 680 prostate cancers were observed versus 568.3 expected (standardized incidence ratio (SIR) = 1.20; 95% confidence interval (CI): 1.11–1.29), 440 breast cancers were observed versus 371.5 expected (SIR = 1.18; 95% CI: 1.08–1.30) and 535 colorectal cancers were observed versus 464.6 expected (SIR = 1.15; 95% CI: 1.06–1.25). When basal cell, squamous cell and skin melanoma were considered separately, all the SIRs for prostate, breast and colorectal cancers were around or slightly above unity. Likewise, the results were consistent across strata of age at skin cancer diagnosis and location (head and neck versus others), and for male and female colorectal cancers. These findings, based on a population with a long tradition of systematic histologic examination of all surgically treated skin lesions, do not support the hypothesis that prostate, breast and colorectal cancer risk is decreased following skin cancer. Β© 2008 Wiley‐Liss, Inc.


πŸ“œ SIMILAR VOLUMES


Response: Risk of prostate, breast and c
✍ Isabelle Soerjomataram; Esther de Vries πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 48 KB πŸ‘ 1 views

## Dear Sir, Recently, Levi et al. 1 reported the risks of developing a prostate, breast or colorectal cancer after an initial skin cancer diagnosis. The hypothesis was that skin cancer patients would have higher vitamin D levels through higher sun exposure and would, therefore, be at reduced risk

Smoking and survival after breast cancer
✍ Michelle D. Holmes; Susan Murin; Wendy Y. Chen; Candyce H. Kroenke; Donna Spiege πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 89 KB πŸ‘ 1 views

## Abstract We examined whether a history of smoking is associated with an increased risk of death from any cause or from breast cancer, among women diagnosed with breast cancer. This was a prospective observational study among 5,056 women from the Nurses' Health Study with Stages I–III invasive br

Family history and survival after colore
✍ Adam J. Bass; Jeffrey A. Meyerhardt; Jennifer A. Chan; Edward L. Giovannucci; Ch πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 94 KB πŸ‘ 2 views

## Abstract ## BACKGROUND A history of colorectal cancer in a first‐degree relative is a recognized risk factor for developing this malignancy. The influence of a family history of colorectal cancer on survival after a diagnosis of colorectal cancer was examined in a large cohort of women. ## MET

Genetic variation in SIPA1 in relation t
✍ Mia M. Gaudet; Kent Hunter; Paul Pharoah; Alison M. Dunning; Kristy Driver; Jola πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 84 KB πŸ‘ 2 views

## Abstract Genetic variation in __SIPA1__, __signal‐induced proliferation‐associated gene 1__, has been proposed to be associated with aggressive breast tumor characteristics related to metastasis and worse prognosis in humans and rodents. To test this hypothesis, we genotyped 3 single nucleotide